Philippine Daily Inquirer1h
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
pharmaphorum4h
GH Research leaps on psychedelic data in depression
GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD ...
BioPharma Dive23h
Shares of psychedelics biotech nearly double on depression data
The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...
poncacitynow5h
FDA Expands Approval for Antidepressant Nasal Spray
The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
stocknews22h
3 Dividend Growth Stocks Perfect for Long-Term Investors
Dividend growth stocks offer a balance of stability and compounding returns, and here are three standout companies with ...